Why Pfizer Is a Much Better Stock Than You Might Think
I can sum up 's (NYSE: PFE) stock performance over the last couple of years in one word (and only three letters): ugh. Shares of the big drugmaker have plunged more than 50% since the high set in late 2022.
Pfizer's revenue and earnings are sinking like a brick. Big hurdles for the company lie ahead. All in all, this big pharma stock might look like one that investors won't want to touch with a 10-foot pole.
However, I'm actually bullish about Pfizer over the long term. Here's why it's a much better stock than you might think.
Source Fool.com
Pfizer Inc. Stock
€28.35
1.870%
The stock is one of the favorites of our community with 28 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a positive potential of 44.65% compared to the current price of 28.35 € for Pfizer Inc..
